Ionis Pharmaceuticals (IONS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist

35.630
+0.040+0.11%

Close Dec 20 16:00 ET

35.500
-0.130-0.36%

Post 20:01 ET

5.63BMarket Cap-14.60P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sector Update: Health Care Stocks Mixed Premarket Friday
MT NewswiresDec 20 09:04 ET
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
BenzingaDec 20 09:01 ET
Express News | Needham Maintains Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
BenzingaDec 20 07:18 ET
Ionis Pharmaceuticals Analyst Ratings
BenzingaDec 20 07:16 ET · Ratings
Ionis Pharmaceuticals Reports FDA Approval of Tryngolza
TipRanksDec 20 06:35 ET
Ionis Pharmaceuticals Says FDA Approved Familial Chylomicronemia Syndrome Drug
MT NewswiresDec 20 04:36 ET

Comments

Just Care Bears

21 hours ago

$Ionis Pharmaceuticals (IONS.US)$ got a good FDA approval and it’s going down crazy 😎

Meltyy

Dec 17 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...